Cyanopyrroles
    1.
    发明申请
    Cyanopyrroles 有权
    青色

    公开(公告)号:US20050256110A1

    公开(公告)日:2005-11-17

    申请号:US11184313

    申请日:2005-07-19

    摘要: This invention provides a progesterone receptor antagonist of formula 1 having the structure wherein, T is O, S, or absent; R1, and R2 are each, independently, hydrogen, alkyl, substituted alkyl; or R1 and R2 are taken together form a ring and together contain —CH2(CH2)nCH2—, —CH2CH2CMe2CH2CH2—, —O(CH2)pCH2—, —O(CH2)qO—, —CH2CH2OCH2CH2—, or —CH2CH2NR7CH2CH2—; n=1-5; p=1-4; q=1-4; R3 is hydrogen, OH, NH2, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, or CORA; RA is hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R4 is hydrogen, halogen, CN, NH2, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R5 is hydrogen, alkyl, or substituted alkyl; R6 is hydrogen, alkyl, substituted alkyl, or CORB; RB is hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R7 is hydrogen or alkyl; or a pharmaceutically acceptable salt thereof.

    摘要翻译: 本发明提供具有以下结构的式1的孕酮受体拮抗剂,其中T为O,S或不存在; R 1,R 2和R 2各自独立地为氢,烷基,取代的烷基; 或R 1和R 2一起形成环,并且一起含有-CH 2(CH 2)2 CH 2 CH 2 - , - CH 2 CH 2 CH 2 CH 2 N 2 CH 2 2 CH 2 - , - O(CH 2)2 CH 2 - , - (CH 2 CH 2) O(CH 2 CH 2)q O - , - CH 2 CH 2 OCH 2 - / SUB CH 2,或CH 2 CH 2,NR 7,CH 2,CH 2, CH 2 - ; n = 1-5; p = 1-4; q = 1-4; R 3是氢,OH,NH 2,烷基,取代的烷基,烯基,取代的烯基,炔基,取代的炔基或COR A。 R A是氢,烷基,取代的烷基,烷氧基,取代的烷氧基,氨基烷基或取代的氨基烷基; R 4是氢,卤素,CN,NH 2,烷基,取代的烷基,烷氧基,取代的烷氧基,氨基烷基或取代的氨基烷基; R 5是氢,烷基或取代的烷基; R 6是氢,烷基,取代的烷基或COR B; R B是氢,烷基,取代的烷基,烷氧基,取代的烷氧基,氨基烷基或取代的氨基烷基; R 7是氢或烷基; 或其药学上可接受的盐。